Claire Poulard

Director/Board Member at

Antabio SAS

Health Technology

Finance

Profile

Claire Poulard is currently Director at Antabio SAS, Turenne Capital Partenaires SA, Newronika SRL, and AlgoTherapeutix SAS. At Omnes Capital SAS, the role started in 2015, with the title of Principal beginning in 2020, and currently holds the title of Partner.
Former roles include Director at Horama SA, AgomAb Therapeutics NV, and NH TherAguix SAS.

Claire Poulard active positions

Companies	Position	Start
Omnes Capital SAS /Venture/ Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes-Venture is an active manager which aims to combine an industrial and strategic overview of their target sectors with operational support for investee companies and financial optimization of investments. The firm takes minority stakes in recently founded businesses with strong European and international potential, focusing on the electronics, software, telecoms, life sciences and web technology services sectors. Their investment policy draws on exclusive sources of deal flow, including the management team's personal networks and privileged links to incubator funds, start-up funds, research labs, fundraisers and Crdit Agricole group's proprietary networks. They typically invest between 2 and 10 million euros. Omnes-Venture partners with investee companies, taking seats on supervisory boards or the board of directors, while respecting investee management's independence. They contribute to the company's strategy and development opportunities, select candidates for key positions in investee companies, working to optimize their financial resources and source industrial and financial partnerships.	Private Equity Investor	12/04/2018
Antabio SAS Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs	Director/Board Member	-
Newronika SRL Newronika SRL Medical SpecialtiesHealth Technology Manufactures medical and electro-medical equipment and appliances	Director/Board Member	-
Algotherapeutix SAS Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies	Director/Board Member	-
Turenne Capital Partenaires SA Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million.	Director/Board Member	-
Omnes Capital SAS Omnes Capital SAS Investment ManagersFinance Omnes Capital invests in companies located in Europe and North America. The firm targets companies operating in the fields of energy transition, renewable energy, sustainable cities and deeptech. It participates in LBOs, MBO, buy-outs and growth equity investment. It also takes minority stakes.	Private Equity Investor	-

All active positions of Claire Poulard

Former positions of Claire Poulard

Companies	Position	End
Horama SA Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases	Director/Board Member	-
NH THERAGUIX SAS	Director/Board Member	-
AGOMAB THERAPEUTICS NV	Director/Board Member	-

See the detail of Claire Poulard's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Claire Poulard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Turenne Capital Partenaires SA Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million.	Finance
Omnes Capital SAS Omnes Capital SAS Investment ManagersFinance Omnes Capital invests in companies located in Europe and North America. The firm targets companies operating in the fields of energy transition, renewable energy, sustainable cities and deeptech. It participates in LBOs, MBO, buy-outs and growth equity investment. It also takes minority stakes.	Finance
Omnes Capital SAS /Venture/ Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes-Venture is an active manager which aims to combine an industrial and strategic overview of their target sectors with operational support for investee companies and financial optimization of investments. The firm takes minority stakes in recently founded businesses with strong European and international potential, focusing on the electronics, software, telecoms, life sciences and web technology services sectors. Their investment policy draws on exclusive sources of deal flow, including the management team's personal networks and privileged links to incubator funds, start-up funds, research labs, fundraisers and Crdit Agricole group's proprietary networks. They typically invest between 2 and 10 million euros. Omnes-Venture partners with investee companies, taking seats on supervisory boards or the board of directors, while respecting investee management's independence. They contribute to the company's strategy and development opportunities, select candidates for key positions in investee companies, working to optimize their financial resources and source industrial and financial partnerships.	Finance
Antabio SAS Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs	Health Technology
Newronika SRL Newronika SRL Medical SpecialtiesHealth Technology Manufactures medical and electro-medical equipment and appliances	Health Technology
Horama SA Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases	Health Technology
AgomAb Therapeutics NV AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues	Health Technology
NH TherAguix SAS NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy	Health Technology
Algotherapeutix SAS Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies	Health Technology